J. Wolchko | executive |
Edward Dulac | executive |
Michael Yee | analyst |
Yigal Nochomovitz | analyst |
Tara Bancroft | analyst |
Tazeen Ahmad | analyst |
Daina Graybosch | analyst |
Michael Ulz | analyst |
Peter Lawson | analyst |
Carolina Ibanez-Ventoso | analyst |
Omotolani Uthman | analyst |
Yanan Zhu | analyst |
Ethan Markowski | analyst |
Welcome to the Fate Therapeutics Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, president and CEO of Fate Therapeutics.
Thank you. Good afternoon, and thanks, everyone, for joining us for the Fate Therapeutics Fourth Quarter 2023 Financial Results Call.